TG Therapeutics, Inc. planned insider sales
In the twelve months since 11 October 2025 insiders at TG Therapeutics, Inc. filed 2 Form 144 notices of planned sales, 10,000 shares worth $437,644 at the time of filing, from 2 sellers. The latest, filed 10 September 2026: Charney Laurence N (director), 5,000 shares worth $274,794, planned for around 10 September 2026 through Fidelity Brokerage Services LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|
| 10 September 2026 | Charney Laurence N | Director | 5,000 | $274,794 | 10 September 2026 | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
| 24 November 2025 | Echelard Yann | Director | 5,000 | $162,850 | 24 November 2025 | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read more
Value is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.Source
Form 144 filings on EDGAR for TG Therapeutics, Inc.: the company's filing index, each notice read from its own XML.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.